Skip to main content

Table 1 Background data at T1 for patients (N = 36). All figures represent number of patients unless stated

From: Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study

  T1 T2 T3 T4
Male 19 (53%)    
Female 17 (47%)    
Mean age (SD) 60 (10%)    
Married/cohabiting 25 (70%)    
Working 7 (19%)    
On sick leave 14 (39%)    
Old age pensioner 15 (42%)    
Metastatic 25(70%) 28 (78%) 28 (78%) 28 (78%)
Levels of Chromogranin A, nmol/liter (ref < 4) 37 42 53 76
Levels of U-5HIAA, μmol/h (ref < 2.1) 13 12 23 14
Mean time since surgery, months1,2 (SD) 3.1 (2.5)    
Interferon 5 (14%) 8 (22%) 6 (27%) 4 (11%)
Octreotid 5 (14%) 6 (27%) 6 (27%) 6 (27%)
Interferon and Octreotid 6 (27%) 10 (28%) 12 (33%) 9 (25%)
Other (Chemotherapy) 4 (11%) 5 (14%) 6 (27%) 3 (<1%)
Octreotid and chemotherapy - - - 1 (<1%)
No treatment 16 (44%) 7 (19%) 6 (27%) 13 (36%)
  1. 1 14 patients had surgery prior to the first admission to the Department of Endocrine Oncology.
  2. 2 3 patients had surgery between the first and second admission to the Department of Endocrine Oncology.